Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure.
Campiani G, Cappelli A, Nacci V, Anzini M, Vomero S, Hamon M, Cagnotto A, Fracasso C, Uboldi C, Caccia S, Consolo S, Mennini T.
Campiani G, et al. Among authors: vomero s.
J Med Chem. 1997 Oct 24;40(22):3670-8. doi: 10.1021/jm970376w.
J Med Chem. 1997.
PMID: 9357534